Johnson & Johnson Biom X Inc. Transaction History

Johnson & Johnson

  • $314 Million
  • Q3 2024

A detailed history of Johnson & Johnson transactions in Biom X Inc. stock. As of the latest transaction made, Johnson & Johnson holds 192,321 shares of PHGE stock, worth $138,471. This represents 0.06% of its overall portfolio holdings.

Number of Shares
192,321
Previous 1,923,201 90.0%
Holding current value
$138,471
Previous $653,000 69.98%
% of portfolio
0.06%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.14 - $1.4 $242,323 - $2.42 Million
-1,730,880 Reduced 90.0%
192,321 $196,000
Q1 2024

May 10, 2024
SELL
$0.21 - $0.69 $44,142 - $145,038
-210,201 Reduced 9.85%
1,923,201 $865,000
Q3 2021

Nov 12, 2021
BUY
$30.6 - $58.1 $65.3 Million - $124 Million
2,133,402 New
2,133,402 $6.53 Million

Others Institutions Holding PHGE

# of Institutions
2
Shares Held
301K
Call Options Held
0
Put Options Held
0
View Full List

About BiomX Inc.

PHGE Quotes by TradingView
  • Ticker PHGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,982,300
  • Market Cap $21.6M
  • Description
  • BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...
More about PHGE
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email